Combination of Oral WX-671 Plus Capecitabine vs. Capecitabine Monotherapy in First-line Her2-negative Metastatic Breast Cancer

Institut Jules Bordet Oncologie Médicale, Brussels

AZ Klina, Oncology Department, Brasschaat

CHU de Liège, Domaine Universitaire de Sart-Tilman, Oncology Department, Liège

Irmandade de Misericórdia da Santa Casa de Porto Alegre, Porto Alegre

Montefiore Medical Center Weiler Division Department, New York

Fox Chase Cancer Center, Philadelphia

Instituto Nacional do Câncer - INCA, Rio de Janeiro

Bethesda KH, Mönchengladbach

Universitys Hospital Case Medical Center, Cleveland

Universitätsklinikum Essen, Innere Klinik und Poliklinik (Tumorforschung), Essen

Davidof Center, Rabin Medical Center, Department of Oncology, Petah Tikva

Sheba Medical Center, Department of Oncology, Tel Litwinsky

Uniklinik Frankfurt, Zentrum der Frauenheilkunde und Geburtshilfe, Frankfurt am Main

Assaf Harofeh medical center, Department of Oncology, Ẕerifin

Kaplan Medical Center, Department of Oncolocy, Rehovot

Department of Obstetrics and Gynecology, Technical University, Munich

Gemeinschaftspraxis Dr. Brudler, Dr. Heinrich, Dr. Bangerter, Augsburg

Instituto Brasileiro de Controle do Câncer - IBCC, São Paulo

Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Uniklinik Köln, Cologne

Universitätsklinikum der Martin-Luther-Universität Halle-Wittenberg, Poliklinik Gynäkologie, Halle